As a result of the rapidly-spreading Omicron variant, this week saw the biggest spike in Covid case numbers since records began in March 2020, with 119,789 positive tests reported in the 24 hours to ...

As the coronavirus pandemic continues to rage across the world, diagnostic tests have been some of the most powerful weapons against the virus spread. There has been a slew of different tests thrown ...

Only a few years ago the benefits of lateral flow diagnostic tests weren’t widely understood outside of scientific circles. The reason most people came into contact with the technology was through the ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

Polymerase chain reaction (PCR) tests were the first available for spotting the coronavirus. They work by detecting the virus’s genetic material, and are very accurate. Then came rapid tests, also ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Andrew Lee has previously received research funding from the National Institute for Health Research. He is a member of the UK Faculty of Public Health and the Royal Society for Public Health. Just as ...

A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...

After over two years, we're finally seeing a return to somewhat of a 'normal' life in a post-pandemic world, with the government recently announcing its plans for how we'll be "living with COVID-19".

Free Covid tests will now be available only to vulnerable groups and some NHS staff, as the government ends free testing for the majority of the population. From our morning news briefing to a weekly ...

HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...

A team from the Universitat Politècnica de València (UPV), the Universitat de València (UV), and the Centro de Investigación Biomédica en Red sobre Enfermedades Raras (CIBERER) has developed a lateral ...